MASH is a complex metabolic disease which can require the use of multiple mouse models to evaluate mechanistic details. Utilize JAX’s expansive portfolio of MASH models to support your research needs and validate key phenotypic endpoints including hepatic steatosis, ballooning, inflammation, and fibrosis.

Confidently access the right platform for your study, and characterize various phenotypes and readouts.

Establish your proof-of-concept with access to JAX preclinical solutions and study-ready cohorts.
Preclinical Solutions
In-Vivo Pharmacology - Leverage definitive solutions for basic research and therapeutic development to advance your field of study.
STZ-Induced Diabetes - JAX has extensive experience creating a variety of STZ-induced Diabetes models to facilitate your metabolic research.
MSNASH Technical Spec Sheet